The nomenclature LOC643008 Activators suggests a theoretical group of chemical substances designed to specifically bind to and increase the activity of a protein that would be encoded by a genetic locus named LOC643008. As of the latest scientific data available to me, LOC643008 does not correspond to any documented gene or protein, therefore any discussion regarding substances described as LOC643008 Activators must be considered a speculative exercise. Assuming LOC643008 were a valid and characterized gene, activators targeting this gene product would be molecules that engage in direct or indirect interactions to upregulate its biological activity. The interactions could be diverse, potentially including direct binding to the protein's active site to enhance its function, binding to an allosteric site to induce a favorable conformational change, or modulation of the protein's interactions with other cellular machinery to amplify its activity. The discovery and validation of such activators would likely involve a variety of in vitro assays to measure the increase in activity of the protein in the presence of these molecules, alongside computational modeling to predict potential binding sites and affinities.
To gain a comprehensive understanding of LOC643008 Activators, a series of detailed studies would be necessary. These would encompass both biophysical and biochemical techniques. For instance, researchers might utilize affinity-based assays, such as fluorescence resonance energy transfer (FRET) or enzyme-linked immunosorbent assays (ELISA), to quantify the interaction between the LOC643008 protein and potential activators. Structural biology methods like X-ray crystallography or cryo-electron microscopy would be invaluable for elucidating the molecular details of where and how these activators bind to the protein. Such structural insights could reveal not only the precise binding pocket but also any conformational rearrangements of the protein that occur upon activation. Complementary to these experimental approaches, in silico modeling, such as molecular docking and dynamics simulations, would provide predictive insights into the interaction patterns and might help in identifying key amino acid residues involved in the activation process. This integrative strategy, combining empirical data with computational predictions, would be essential to thoroughly characterize the mechanism of action of LOC643008 Activators at the molecular level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound is a DNA methyltransferase inhibitor that can reactivate silenced genes, potentially affecting antisense RNA expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C, which can lead to changes in gene expression patterns, including those of antisense RNAs. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
As a histone deacetylase inhibitor, it can alter chromatin structure and induce gene expression, which may include antisense RNAs. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts on nuclear receptors and can modify the expression of genes and associated antisense RNAs. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Although primarily known to inhibit transcription, it can also cause upregulation of certain genes and potentially antisense RNAs as a stress response. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This histone deacetylase inhibitor can change the expression levels of numerous genes, possibly affecting antisense RNA molecules. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate can cause changes in gene expression as a consequence of its effects on folate metabolism and DNA synthesis. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium affects several signaling pathways, such as the Wnt pathway, which could lead to a change in gene expression including antisense RNAs. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide interferes with DNA replication and can alter gene expression profiles, which may extend to antisense RNAs. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to GC-rich DNA sequences, it can specifically alter the transcription of certain genes, potentially impacting antisense RNA expression. | ||||||